Pediatric Immunization

The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 years against five meningococcal serogroups, the company announced.

Kindergarten vaccine coverage has been on a steady decline since the 2019-2020 school year, and fewer parents felt it was important for their teens to receive all recommended vaccines in 2023 compared with 2021.

Nearly 80% of infants born in a California health system were exposed to nirsevimab or the maternal respiratory syncytial virus vaccine in 2023-2024, the first season in which they were available, according to study findings.

Nearly one in six U.S. children received at least one vaccine dose outside the recommended age guidelines during a recent 10-year period, according to study findings published in Pediatrics.

Routine childhood immunizations have prevented 1.1 million deaths in the United States since the CDC’s Vaccines for Children program launched in 1994, according to researchers.

The FDA accepted a biologics license application for Merck’s respiratory syncytial virus immunization, clesrovimab, the company announced Tuesday.

Nirsevimab and the maternal vaccine for respiratory syncytial virus can reduce health care costs and productivity losses associated with RSV but lead to higher overall spending, according to analyses published in Pediatrics.

Incorporating immunization screening and adding a designated nurse vaccinator appeared to improve vaccine uptake at a pediatric urgent care clinic in San Francisco, according to a single-center study published in Pediatrics.

NEW YORK — As vaccination coverage declines globally, pediatricians need to prepare to encounter more measles cases in their communities, according to a presentation at the Infectious Diseases in Children Symposium.

Another monoclonal antibody for preventing respiratory syncytial virus disease in infants could enter the market as early as next year, based on the results of two studies presented at IDWeek, Merck said.